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Introduction: Npas4 is a calcium-dependent transcription factor expressed within neurons of the brain where it
regulates the expression of several genes that are important for neuronal survival and synaptic plasticity. It is known
that in the adult brain Npas4 plays an important role in several key aspects of neurobiology including inhibitory
synapse formation, neuroprotection and memory, yet very little is known about the role of Npas4 during
neurodevelopment. The aim of this study was to examine the expression and function of Npas4 during nervous
system development by using a combination of in vivo experiments in the developing mouse embryo and neural
differentiation of embryonic stem cells (ESCs) as an in vitro model of the early stages of embryogenesis.
Methods: Two different neural differentiation paradigms were used to investigate Npas4 expression during
neurodevelopment in vitro; adherent monolayer differentiation of mouse ESCs in N2B27 medium and Noggin-
induced differentiation of human ESCs. This work was complemented by direct analysis of Npas4 expression in the
mouse embryo. The function of Npas4 in the context of neurodevelopment was investigated using loss-of-function
experiments in vitro. We created several mouse ESC lines in which Npas4 expression was reduced during neural
differentiation through RNA interference and we then analyzed the ability of these Npas4 knockdown mouse ESCs
lines to undergo neural differentiation.
Results: We found that while Npas4 is not expressed in undifferentiated ESCs, it becomes transiently up-regulated
during neural differentiation of both mouse and human ESCs at a stage of differentiation that is characterized by
proliferation of neural progenitor cells. This was corroborated by analysis of Npas4 expression in the mouse embryo
where the Npas4 transcript was detected specifically in the developing forebrain beginning at embryonic day 9.5.
Finally, knockdown of Npas4 expression in mouse ESCs undergoing neural differentiation affected their ability to
differentiate appropriately, resulting in delayed neural differentiation.
Conclusions: Here we provide the first evidence that Npas4 is expressed during embryonic development and that
it may have a developmental role that is unrelated to its function in the adult brain.Introduction
Neuronal PAS domain protein 4 (Npas4) is a transcription
factor belonging to the basic helix-loop-helix Per-Arnt-
Sim (bHLH PAS) family of regulatory proteins [1-3].
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cellular response to environmental stresses and circa-
dian rhythm [4]. In the adult organism, expression of
Npas4 is largely restricted to the brain [2,5,6] where it is
expressed predominantly in excitatory neurons in re-
sponse to neuronal activity-mediated calcium (Ca2+)
signaling [7]. Unlike most other bHLH PAS proteins,
which are continually expressed but are regulated at the
post-translational level [4], Npas4 expression is regulated
primarily at the level of transcription. Up-regulation of
Npas4 mRNA is independent of de novo protein synthesis,
occurs within minutes and is dependent on nuclear Ca2+td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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as a direct link between changes in intracellular Ca2+
levels and rapid changes in gene expression.
Through its regulation of various activity-dependent
transcriptional programs, Npas4 is involved in several
aspects of neuronal homeostasis. A number of studies
have established the importance of Npas4 in activity-
dependent neuroprotection [5,9,10], but there is now
mounting evidence that Npas4 also plays a critical role
in modulating synaptic plasticity. Npas4 was first impli-
cated in synaptic plasticity when it was identified as a
master regulator of inhibitory synapse formation [7].
More recently, it has been shown that Npas4 is induced
by learning and also has a functional role in memory
formation [8,11].
To date, there are few Npas4 target genes that have
been experimentally validated, although several of the
genes identified thus far have been implicated in neuronal
plasticity. One component of the transcriptional program
regulated by Npas4 is brain-derived neurotrophic factor
(Bdnf ) [7,12], a multifaceted neurotrophin that is im-
portant in the development and function of the nervous
system due to its roles in neuronal survival, differentiation
and synaptic plasticity [13-16]. Another is developmentally
regulated brain protein (Drebrin) [3]. The Drebrins are
actin binding proteins that have roles in early synapto-
genesis and synaptic function through modulation of
dendritic spine morphology [17,18].
While significant progress has been made in under-
standing the expression, function and targets of Npas4 in
the adult brain, relatively little is known about its expres-
sion during embryogenesis and whether or not it may be
involved in embryonic development. Only two studies
have investigated the expression of Npas4 during develop-
ment and the reports were inconsistent. Despite cloning
the Npas4 complementary DNA (cDNA) from a human
fetal brain library, Ooe et al. were unable to detect Npas4
mRNA expression in the developing mouse embryo using
either in situ hybridization (ISH) or reverse transcription
polymerase chain reaction (RT-PCR) [3]. In contrast,
Hester et al. found Npas4 protein to be expressed in the
dorsal root ganglion of the mouse embryo at embryonic
day 10.5 (E10.5) [5]. The paucity of available data and
the lack of a clear consensus indicate that more research
is required before a definitive conclusion can be made
regarding the expression of Npas4 in the embryo.
Although experimental evidence is still lacking, several
lines of evidence suggest that Npas4 may have a develop-
mental role. Firstly, it is not uncommon for bHLH PAS
transcription factors to have roles in both adulthood and
development. For example, in addition to regulating the
hypoxic response in the adult organism [19-22], hypoxia
inducible factor 1 alpha (Hif1α) is also required for proper
vascularization of the embryo and, consequently, micelacking Hif1α die in utero due to vascularization defects
[23]. Indeed, some researchers have suggested a possible
developmental role for Npas4 due to its similarity to
other bHLH PAS proteins that are involved in regulat-
ing various aspects of embryonic development. Npas4
falls within a subset of bHLH PAS proteins that have a
tissue-restricted expression pattern and are not dependent
on pre-activation (such as ligand binding or protein
stabilization) to form transcriptionally active dimers.
Other factors belonging to this subgroup include the
D. melanogaster proteins single-minded and trachealess,
both of which have critical roles in development [24-26].
Moser et al. have proposed that since Npas4 shares a
similar mode of action to these proteins it could also be
important for embryonic development [2].
Secondly, consideration of evolutionarily related genes
also supports the notion that Npas4 may have a role
during development. The D. melanogaster homolog of
Npas4, dysfusion (Dys), is expressed during embryogenesis
and, indeed, is essential for normal development [27,28].
Given that Npas4 and Dys are descended from a common
ancestral protein, it is possible that some aspects of
the developmental expression or function of Dys are
conserved in the mammalian Npas4 proteins.
Thirdly, several Npas4 target genes are known to be
important for nervous system development. The embry-
onic isoform of Drebrin, Drebrin E, plays a role in axonal
growth during development [29,30] while disruption of
Bdnf signaling has profound consequences for neuronal
survival resulting in death during the first few weeks of
life [31,32].
Lastly, a computational analysis which examined net-
works of interacting bHLH transcription factors predicted
that Npas4, together with NeuroD6, a neurogenic bHLH
transcription factor important for neuronal differentiation
and survival [33,34], may be part of a transcriptional
regulatory module which is important in mouse brain
development [35].
In this study, we used neural differentiation of embry-
onic stem cells (ESCs) as a model of neurogenesis to in-
vestigate the expression and function of Npas4 from a
neurodevelopmental point of view. Differentiation of ESCs
in vitro recapitulates many of the fundamental cellular
and molecular events occurring during the early stages of
embryogenesis [36,37] making them a useful model in
which complex processes can be studied in a simplified
and much more accessible way without the complexity of
a whole organism. Here, we show that Npas4 is transiently
up-regulated during neural differentiation of both mouse
and human ESCs at a time which coincides with the
proliferation of neural progenitor cells in culture. We
also demonstrate that Npas4 is expressed specifically in
the developing forebrain of the mouse embryo at a stage
of development that is crucial for patterning of the
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pression in mouse ESCs undergoing neural conversion
impairs their ability to differentiate appropriately result-
ing in a delayed neural differentiation phenotype. Over-
all, our results indicate a presumptive role for Npas4 in
early mammalian central nervous system (CNS) devel-
opment that has been hitherto undefined.Materials and methods
Ethics statement
All animals were housed and treated in accordance with
the Australian Code of Practice for the Care and Use of
Animals for Scientific Purposes. The University of Adelaide
Animal Ethics Committee approved all experiments prior
to their commencement.Cell culture
Cell lines used in this study were: D3 [38] and 46C [39]
mouse embryonic stem cells (mESCs) and the Envy [40]
human embryonic stem cell (hESC) line. Routine culture
of mESCs has been described previously [41].
N2B27 differentation of mESCs: the method used for
neural differentiation of mESCs as a monolayer has been
described previously [42]. Briefly, mESCs were plated
onto 0.1% gelatin coated dishes in N2B27 medium at a
density of 1 × 104 cells/cm2. Cells were cultured in a 37°C
incubator containing a mixture of 95% air/5% CO2 and
N2B27 medium was replaced every two days.
Noggin-induced differentiation of hESCs: the methods
used for routine culture and neural differentiation of hESCs
have been described previously [43]. Briefly, neural induction
of hESCs was initiated by treatment with recombinant Nog-
gin (500 ng/mL) for 14 days. To form neurospheres, Noggin
treated hESC colonies were dissected and transferred to
serum free medium supplemented with epidermal growth
factor (20 ng/mL) and fibroblast growth factor (20 ng/mL).Flow cytometry
Cells were dissociated using trypsin, resuspended in PBS
and the suspension was passed through a 70 μm cell
strainer to remove any aggregates. Cells were then analyzed
for GFP expression using a FACSCanto™ Flow Cytometer
(BD Biosciences, Franklin Lakes, New Jersey, USA) and
data were analyzed using FACSDiva™ (BD Biosciences,
Franklin Lakes, New Jersey, USA) software. Cells were first
gated to remove any cell debris or doublets and subse-
quently were gated to exclude the negative control D3
mESC line from the GFP positive pool - the threshold GFP
fluorescence was set such that 99% of D3 cells were ex-
cluded and only cells whose fluorescence intensity was
greater than this level were scored as GFP+.Immunocytochemistry
Cells were fixed in 4% paraformaldehyde (PFA) for
20 minutes at room temperature and then permeabilized
using blocking solution (10% (v/v) horse serum in PBS
with 0.1% Tween 20 (0.1% PBST)) for 60 minutes at
room temperature. Cells were then incubated with the
anti-Nestin antibody (Abcam, Cambridge, England,
Ab5968; 1/800 in blocking solution) overnight at 4°C.
After washing in 0.1% PBST, cells were incubated
with the anti-rabbit Cy2 secondary antibody (Jackson,
Pennsylvania, USA, 711-225-152; 1/200 in blocking solution)
for two hours at room temperature. After washing in 0.1%
PBST, cells were then incubated in 300 nM 4′,6-diamidino-2-
phenylindole (DAPI) for 10 minutes at room temperature
after which they were washed twice in 0.1% PBSTand viewed
under fluorescence microscopy. For quantification of Nestin
expression, ImageJ was used to calculate the Nestin:DAPI ra-
tio. For each field, the overall fluorescence intensity was calcu-
lated for each color channel and from this the ratio of Nestin:
DAPI fluorescence was determined.
Immunoblotting
Cells were lysed using lysis buffer (50 mM Tris–HCl
pH8.0, 150 mM NaCl, 1% (v/v) NP-40, 1% (w/v) sodium
deoxycholate, 0.1% (w/v) sodium dodecyl sulfate) containing
protease inhibitor cocktail (Roche, Basel, Switzerland).
Following sodium dodecyl sulfate polyacrylamide gel
electrophoresis (SDS-PAGE), proteins were transferred
onto a 0.45 μm Immobilon P PVDF membrane (Millipore™,
Billerica, Massachusetts, USA) and, after blocking, the
membranes were incubated overnight at 4°C with the
appropriate primary antibody diluted in 0.1% PBST (Actin
(Sigma-Aldrich, St. Louis, Missouri, USA, A2066; 1/5,000),
GFP (Rockland, Pennsylvania, USA, 600-101-215; 1/2,500),
Npas4 (kind gift from Yingxi Lin; 1/15,000)). After washing,
membranes were incubated with the appropriate horse radish
peroxidase (HRP)-conjugated secondary antibody diluted in
0.1% PBST (anti-goat-HRP (Rockland, 605-4302; 1/60,000),
anti-mouse-HRP (Rockland, 610-703-124; 1/60,000), anti-
rabbit-HRP (Rockland, 611-703-127; 1/60,000)) for two hours
at room temperature. Proteins were detected using Immobi-
lon™Western Chemiluminescent HRP Substrate (Millipore™)
according to the manufacturer’s instructions. Chemilumines-
cent signal intensity was quantified by densitometry analysis
using ImageJ software.
Alkaline phosphatase staining
The Alkaline Phosphatase Detection Kit (Millipore™) was
used to assay for alkaline phosphatase activity according
to the manufacturer’s instructions.
Growth rate assays
Undifferentiated mESCs: cells were plated in six-well
plates (9 × 103 cells/cm2) and the number of living cells
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days using the vital stain trypan blue.
N2B27 differentiation: on Day 0, ESCs were plated onto
35 mm dishes (8 × 104 cells/dish) in N2B27 medium and
the number of living cells was counted at 24 hour intervals
over a period of ten days using the vital stain trypan blue.
In situ hybridization
N2B27 cultures in vitro: The ISH probes used to detect
Npas4 mRNA expression have been used previously [1].
A 991 bp segment of Npas4 cDNA was amplified using
the following primers (TATGAGAAGTTGCCCCCAAG;
CGGTGAGGAAGTGAGACTCC) and was cloned into
the multiple cloning site of the pGEM® T Easy vector
(Promega, Fitchburg, Wisconsin, USA). The probe se-
quence was confirmed by sequencing using pUC/M13
primers (GTTTTCCCAGTCACGAC; CAGGAAACAG
CTATGAC) and 50 ng of plasmid DNA was used as a
template to amplify a linear DNA fragment containing
the Npas4 probe sequence by PCR using pUC/M13
primers. PCR product (10 μg) was digested with either
SacI or SacII. Digested PCR fragments were purified by
agarose gel electrophoresis and excision using QIAquick®
Gel Extraction Kit (QIAGEN®), Hilden, Germany accord-
ing to the manufacturer’s instructions. Purified DNA
(3.5 μg) was used as template to make a DIG labeled
riboprobe using in vitro transcription. Following this,
unbound DIG-11-UTP was removed using a Nanosep®
Centrifugal Device (Pall Corportation, PortWashington, New
York, USA) according to themanufacturer’s instructions.
Cells were fixed in 4% PFA for 20 minutes, washed
twice with PBS and dehydrated through a series of as-
cending methanol/PBS washes (25%, 50%, 75%, 100%).
Cells were immersed in 100% methanol and left over-
night at 20°C and the following day cells were rehy-
drated with a series of descending methanol/PBS washes
(75%, 50%, 25%, 0%). Cells were then permeabilized by
washing in 0.1% PBST for 30 minutes after which they
were again fixed in 4% PFA for 20 minutes. This was
followed by three washes of five minutes each in 0.1%
PBST and then one five minute wash in a 1:1 mixture of
hybridization buffer (50% (v/v) formamide, 5X saline
sodium citrate (SSC), 0.1% (v/v) Tween 20, 40 μg/mL
salmon sperm DNA) and PBS. Subsequently, cells were
incubated in hybridization buffer for 60 minutes at 65°C
after which this was replaced with fresh hybridization
buffer containing the DIG-labeled riboprobe (175 ng/mL)
which was heated for two minutes at 80°C and then
cooled for five minutes on ice prior to addition to the
hybridization buffer. Hybridization was allowed to proceed
overnight at 65°C in a humidified chamber. The following
day, cells were washed three times in washing solution
(50% (v/v) formamide, 2X SSC, 0.1% (v/v) Tween 20) for
30 minutes at 65°C and then twice in maleic acid buffer(0.1 M maleic acid, 0.15 M NaCl) for 30 minutes. After
this, cells were incubated in blocking solution (1% (w/v)
blocking reagent (Roche, 11-096-176-001), 10% (v/v) horse
serum in maleic acid buffer) for 60 minutes after which
this was replaced with fresh blocking solution containing
the anti-DIG antibody (Roche, 11-093-274-910; 1/5,000).
Cells were incubated with the anti-DIG antibody over-
night at 4°C and the following day were washed three
times in maleic acid buffer for 20 minutes, followed by
two washes of 10 minutes each in detection buffer (0.1 M
Tris-Cl, 0.1 M NaCl). Coverslips were placed face up onto
a microscope slide and detection solution (2% (v/v) NBT/
BCIP stock solution (Roche, 11-681-451-001) in detection
buffer) was added to the slides (500 μL/slide) and the color
reaction was allowed to develop overnight at room
temperature in the dark. Once color development was
complete, cells were washed three times in PBS, fixed in
4% PFA for 20 minutes and washed twice more in PBS.
Following this, coverslips were placed upside down onto a
drop of mounting medium which has been placed onto a
microscope slide. The mounting medium was allowed to
cure overnight and the following day slides were viewed
microscopically.
Whole-mount mouse embryo: After embryos were
isolated, they were washed three times in PBS and dehy-
drated through a series of ascending methanol/0.1% PBST
washes (25%, 50%, 75%, 100%) of five minutes each. Em-
bryos were immersed in 100% methanol (2x five minutes),
left overnight at 20°C and the following day were rehy-
drated with a series of descending methanol/PBS washes
(75%, 50%, 25%, 0%) of five minutes each. Endogenous
hydrogen peroxide activity was then quenched by incubat-
ing embryos in 6% H2O2 in PBT for one hour at room
temperature. Embryos were then permeabilized with Pro-
teinase K (Cat. # P6556. Sigma-Alrich (St. Louis, Missouri,
USA) (10 μg/mL in PBT) treatment (25 minutes at room
temperature for E8.0, 30 minutes for E9.5 and 35 mi-
nutes for E10.5). Proteinase K activity was arrested by
washing for five minutes at room temperature with
fresh glycine (2 mg/mL in PBT). Embryos were then re-
fixed in 0.2% gluteraldehyde/4% PFA in PBT for 20
minutes at room temperature. Embryos were then washed
twice for five minutes in PBT and rinsed once in a 1:1
mixture of PBT:hybridization solution (hybridization solu-
tion: 50% formamide, 5X SSC, 1% SDS, 50 μg/mL heparin,
50 μg/mL yeast RNA, 0.1% Tween20 in RNase-free water).
Embryos were then rinsed in hybridization solution before
being incubated in hydridization solution for four hours at
70°C with rotation. After blocking, the solution was replaced
with hybridization solution containing DIG-labeled Linked
Nucleic Acid (LNA™, Exiqon (Copenhagen, Denmark))
probes diluted to 20 nM (Npas4 TGATCTGCTGAATGA
GACGAT; Scrambled GTGTAACACGTCTATACGCCCA,
Exiqon 300512–15) and hybridization was allowed to
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day, embryos were washed twice in pre-heated Solution
#1 (50% formamide, 4X SSC, 1% SDS in water) for 30 mi-
nutes at 70°C. Next, embryos were washed once in a 1:1
mixture of Solution #1:Solution #2 (0.5 M NaCl, 10 mM
Tris pH7.5, 0.1% Tween20 in water) for 10 minutes at 70°
C. Embryos were washed three more times in Solution #2
for five minutes at room temperature. Unbound probe was
then degraded by incubating embryos twice in RNase A
(100 ug/mL in Solution #2) for 30 minutes at 37°C. Em-
bryos were then washed once in Solution #2 for five mi-
nutes at room temperature, once in Solution #3 (50%
formamide, 2X SSC, in water) for five minutes at room
temperature, twice in Solution #3 for 30 minutes at 65°C
and three times in Tris buffered saline with 0.1% Tween20
(TBST) for five minutes at room temperature. Embryos
were then blocked by incubating for 1.5 hours in 10% heat-
inactivated sheep serum in TBST. Following this, the block-
ing solution was replaced with fresh blocking solution con-
taining the anti-DIG antibody (Roche, 11-093-274-910; 1/
2,000) and embryos were incubated overnight at 4°C with
rocking. The following day, embryos were washed three
times for five minutes in TBST at room temperature, then
five times for one hour in TBST at room temperature and
then overnight in TBST at 4°C with rocking. The following
day, embryos were washed three times in NTT solution
(0.1 M NaCl, 0.1 M Tris pH9.5, 0.1% Tween20) for 10 mi-
nutes at room temperature. To develop the color reaction,
embryos were incubated at 4°C and protected from light in
NTT solution containing NBT/BCIP stock solution (Roche,
11681451001, 1/50) for several days until staining was vis-
ible. Embryos were then washed twice for 10 minutes in
NTT solution before being washed overnight in PBT at
room temperature. The following day, embryos were fixed
in 0.2% glutaraldehyde/4% PFA for one hour at room
temperature, washed twice for five minutes in PBS and then
transferred to 80% glycerol for imaging.
Generation of stable Npas4 knockdown mESC lines by
lentiviral transduction
MISSION® shRNA constructs (Sigma-Aldrich: pLKO.1-
puro control vector, SHC001; Npas4, SHGLY-NM_153553)
were used to generate Npas4 knockdown and control lenti-
virus. 46C mESCs were transduced and clones were iso-
lated using antibiotic selection (3 μg/mL puromycin for
10 days. Although the 46C mESC line does already inher-
ently carry the puromycin N-acetyl-transferase gene within
its genome, it is under the control of the endogenous
Sry-related high mobility group box 1 (Sox1) promoter
and, therefore, is not actively expressed in undifferenti-
ated mESCs. Thus, we were able to isolate transduced
cells harboring integrated constructs using puromycin
selection while they remained undifferentiated. The se-
quences targeted by the Npas4 knockdown constructs areas follows; Npas4 KD1 - CCTGGATCTTAAACCCTGG
AA, Npas4 KD2 - CGTTTCTGAAAGTGTCCTAAT.
Nucleic acid isolation
Isolation of genomic DNA (gDNA) was performed using
the DNeasy Blood and Tissue Kit (QIAGEN) according to
the manufacturer’s instructions. RNA was isolated using
the High Pure RNA Isolation Kit (Roche) according to the
manufacturer’s instructions. Included in the protocol is a
DNaseI treatment step to remove traces of gDNA.
Reverse transcription
RT was performed using the SuperScript™ III reverse
transcriptase enzyme (Invitrogen™, Carlsbad, California,
USA) according to the manufacturer’s instructions.
Polymerase chain reaction
Primer sequences and PCR conditions are described in
detail in Additional file 1.
Quantitative RT PCR
Quantitative RT PCR (qRT-PCR) reactions were performed
using SYBR® Green PCR Master Mix (Applied Biosystems®,
California, USA) according to the manufacturer’s instruc-
tions using 50 ng of template cDNA. Samples were loaded
in triplicate and thermal cycling was performed using an
ABI PRISM® 7000 Sequence Detection System driven by
ABI PRISM SDS v1.1 software (Applied Biosystems®).
β-actin was used as an internal reference to facilitate
relative quantification using the comparative Ct method
[44]. Primers directed to the Npas4 transcript were
similar in reaction efficiency to the β-actin internal
reference primers.
Mouse embryo collection
Uteri of pregnant mice were collected at the indicated
times and the embryos dissected from the decidua in
cold PBS. For ISH experiments, the C57BL6 strain was
used and embryos were immediately fixed in 4% PFA
overnight at 4°C, while for RT-PCR experiments the
B6CBAF1 strain was used and embryos from the same
litter were pooled and RNA extracted immediately.
Results
Npas4 is transiently expressed during neural
differentiation of ESCs
To characterize the temporal expression profile of Npas4
during neural differentiation of mouse ESCs (mESCs),
46C mESCs were differentiated using the N2B27 method
[42] and RT-PCR was used to assay for Npas4 mRNA
expression at 48 hour intervals over the course of ten
days. Undifferentiated mESCs (Day 0) were also analyzed
to determine whether Npas4 is expressed by pluripotent
mESCs. To place the Npas4 expression profile in context,
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including genes that are expressed by pluripotent ESCs
(Pou5f1), neural progenitor cells (NPCs) (Sox1, Nestin)
and neurons (NF-M). We observed that Npas4 was tran-
siently up-regulated during neural differentiation with
expression commencing at approximately Day 4, once
expression of Pou5f1 was down-regulated, and declining
at around Day 8 just prior to the onset of NF-M expres-
sion (Figure 1A). In this way, the expression pattern of
Npas4 was similar to that of the NPC marker gene Nestin.
When the change in Npas4 expression was quantified
using qRT-PCR, we found that the highest expression of
Npas4 occurred at Day 4 when a 10-fold induction was
observed relative to undifferentiated mESCs (Figure 1B).
We then investigated the spatial expression pattern ofFigure 1 Npas4 expression during neural differentiation of ESCs. (A) R
Npas4 mRNA in relation to various marker genes during N2B27 differentiation
loading control. The negative control reaction (−) contained water in place of
differentiation were quantified using qRT-PCR. At each time point Npas4 expre
Day 0 (undifferentiated mESCs). Mean values and standard deviations of three
analysis of Npas4 mRNA expression at Day 4 of N2B27 differentiation of mESCs
experiments (n = 2) are shown. Top panel - Npas4 antisense probe; Bottom pan
to determine the temporal expression profile of the Npas4 protein during N2B
was used as a loading control (n = 3). (E) Immunoblotting was used to determ
antibody to GFP) and βIII tubulin during N2B27 differentiation of mESCs. An an
(n = 3). (F) RT-PCR analysis of NPAS4 mRNA in relation to various marker genes
the reference gene β-ACTIN were used as a loading control. The negative con
human embryonic stem cells; mESCs, mouse embryonic stem cells; NS, neuroNpas4 during neural differentiation of mESCs using ISH.
After four days of differentiation, a strong signal was ob-
served in virtually all colonies with most of the cells in
each colony showing staining (Figure 1C). In negative
control experiments where a sense probe was used, no
signal was detected in any colonies.
Next, Npas4 protein expression during N2B27 differ-
entiation of mESCs was investigated using immuno-
blotting. Similar to the mRNA profile, Npas4 protein
expression was transient reaching a peak at around Day
4 of differentiation (Figure 1D). The specificity of the
anti-Npas4 antibody was validated by transfecting HEK
293 T cells, which do not express Npas4 protein endogen-
ously, with an Npas4 expression construct (Additional
file 2). Once again, expression of various marker genesT-PCR analysis was used to determine the temporal expression profile of
of mESCs (n = 3). Primers to the reference gene β-actin were used as a
template cDNA. (B) The changes in Npas4 expression during N2B27
ssion was normalized to β-actin expression and fold changes are relative to
independent experiments (n = 3) are displayed. (C) In situ hybridization
. Representative images of differentiating colonies from two independent
el - Npas4 sense probe. Scale bar = 100 μm. (D) Immunoblotting was used
27 differentiation of mESCs. An antibody to the reference protein β-actin
ine the temporal expression profile of Sox1 in the 46C cell line (using an
tibody to the reference protein β-actin was used as a loading control
during Noggin-induced neural differentiation of hESCs (n = 3). Primers to
trol reaction (−) contained water in place of template cDNA. hESCs,
spheres.
Figure 2 Npas4 mRNA expression during mouse embryonic
development. (A) RT-PCR analysis was used to determine Npas4
mRNA expression at various stages of mouse embryonic development
ranging from E6.5 to E9.5. RNA was isolated from mouse embryos at
the indicated developmental stage and this was used as a template
for reverse transcription in a reaction containing either the reverse
transcription enzyme (+RT) or water (-RT). The PCR negative control
reaction (−) contained water in place of template cDNA. Primers to
the reference gene β-actin were used as a positive control for cDNA
synthesis. (B) In situ hybridization was performed on whole-mount
mouse embryos at E8.0, E9.5 and E10.5 using a DIG-labeled LNA
probe that was either complementary to the Npas4 mRNA
(Antisense) or was a non-specific control probe (Scrambled). E,
embryonic day.
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in context. The 46C mESC line [39] is a transgenic GFP
knock-in cell line in which the open reading frame of
the Sox1 gene has been replaced with a dual reporter/
selection cassette containing the sequence coding for
enhanced GFP followed by an internal ribosome entry
site (IRES)-linked puromycin resistance gene such that
both genes are under the control of the endogenous
Sox1 promoter and are expressed concurrently in Sox1+
cells. Thus, using the 46C mESC line we were able to
indirectly assess expression of Sox1 by using an anti-
body to GFP or by using fluorescence microscopy. GFP
expression was present at low levels after four days of
differentiation, peaked between Days 6 and 8 and then
gradually declined from Day 8 onwards (Figure 1E,
Additional file 3). In contrast, the neuronal marker βIII
tubulin was not expressed at significant levels until
around Day 8 (Figure 1E). Thus, Npas4 protein expression
overlapped slightly with that of Sox1 but was down-
regulated prior to the onset of βIII tubulin expression.
To determine whether the pattern of Npas4 expression
observed during neural differentiation of mESCs was
conserved in other mammalian species, the temporal
profile of NPAS4 expression was also investigated during
Noggin-induced neural differentiation of hESCs using
RT-PCR. Samples corresponding to three stages of differ-
entiation were analyzed; undifferentiated hESCs, hESCs
treated with Noggin for 14 days and neurospheres derived
from Noggin-treated hESCs that had been cultured for
19 days. Once again, expression of well-characterized
marker genes was used as a reference point; these in-
cluded markers of pluripotent ESCs (POU5F1), early
NPCs (PAX6, PAX7) and late NPCs (PAX3).
As in the mESC model, we found that NPAS4 mRNA
expression was transiently up-regulated during neural
differentiation of hESCs with NPAS4 mRNA expression
being detected specifically in Noggin-treated hESCs,
but absent in undifferentiated hESCs or neurospheres
(Figure 1F). This was different from the expression of NPC
marker genes PAX6 and PAX7, which were expressed in
both Noggin-treated hESCs and neurospheres.
Npas4 is expressed in the developing mouse embryo
Given that Npas4 was found to be transiently up-
regulated in two independent in vitro models of
neural differentiation, the expression of Npas4 was in-
vestigated in the whole mouse embryo to determine
whether a similar pattern of expression also occurs at
an equivalent stage during murine embryonic develop-
ment in vivo. RNA was extracted from whole embryos
and RT-PCR was used to analyze the temporal profile
of Npas4 mRNA expression at various stages of em-
bryogenesis ranging from E6.5 to E9.5 (Figure 2A).
Using this method, we were able to detect Npas4expression at E9.5 but not at the earlier time points
of E7.5 or E6.5. To validate these findings and to de-
termine the spatial expression pattern of Npas4 in the
embryo, we performed whole-mount ISH using an
Npas4-specific DIG-labeled LNA probe on embryos of
various stages of development from E8.0 to E10.5
(Figure 2B). As a negative control, we used a scram-
bled LNA probe which does not recognize the Npas4
mRNA sequence. Confirming our previous observa-
tions, we did not detect any Npas4 expression prior
to E9.5; however, at E9.5 Npas4 expression was ob-
served exclusively in the prosencephalon. At E10.5
this expression had intensified and expanded caudally.
Thus, Npas4 is expressed in the developing nervous
system of the mouse embryo at a time which coin-
cides with the onset of neurulation and patterning of
the telencephalon.
Figure 3 Knockdown of endogenous Npas4 protein during
neural differentiation of mESCs. (A) Immunoblotting was used to
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differentiation of 46C mESCs
To investigate the role of Npas4 during neural differenti-
ation, RNA interference (RNAi) was used to reduce Npas4
expression in mESCs undergoing differentiation. Given
the pattern of Npas4 expression during embryonic de-
velopment and neural differentiation of ESCs, the 46C
mESC line was selected as the parental cell line for
Npas4 knockdown experiments to facilitate detection of
possible phenotypes affecting Sox1 expression and/or
NPC formation. Lentiviral transduction was used to
introduce small hairpin RNA (shRNA) expression con-
structs into 46C mESCs and antibiotic selection was
used to generate stable, clonally-derived Npas4 knock-
down mESC lines. Two different Npas4 shRNA constructs
were used to create Npas4 knockdown mESC lines (KD1
and KD2) and, in addition, an Empty vector control mESC
line was created to control for the transduction process
and for the introduction of foreign DNA into cells. Im-
munoblotting was used to assess Npas4 expression in the
transduced mESC lines after four days of neural differenti-
ation. Expression of the endogenous Npas4 protein was
reduced in both the Npas4 knockdown mESC lines when
compared to the Empty vector control (approximately
54% reduction in KD1 and 62% reduction in KD2)
(Figure 3A) and, when analyzed using a one-way analysis
of variance (ANOVA), this difference was statistically sig-
nificant (P <0.001) (Figure 3B). In the undifferentiated
state, all of the transduced mESC lines retained normal
growth rates, morphology and expression of several key
pluripotency genes (Additional file 4) suggesting that the
genomic integration of shRNA constructs had not inter-
fered with normal ESC biology and that interpretation of
results would not be affected by off-target integration ef-
fects. Furthermore, no difference was observed between
the Empty vector control mESC line and those constitu-
tively expressing Npas4-specific shRNAs suggesting that
Npas4 is dispensable for normal ESC biology.determine the level of Npas4 protein expression in different mESC
lines (n = 3 biological replicates). Lysates were harvested after four
days of differentiation in N2B27 medium and blots were probed
with an anti-Npas4 antibody. β-actin served as a loading control.
(B) Npas4 knockdown was quantified by densitometry analysis.
Npas4 protein expression in each sample was normalized to β-actin
expression and is relative to Npas4 expression in the Empty vector
control line which was given an arbitrary value of 1. Mean values
and standard deviations of three independent experiments (n = 3
biological replicates) are shown (**P <0.01, one-way ANOVA).
ANOVA, analysis of variance; mESC, mouse embryonic stem cells.Reduced Npas4 expression during neural differentiation
results in delayed neural differentiation
To determine whether reduced Npas4 expression affected
neural differentiation of mESCs, the Npas4 knockdown
mESC lines were compared to the Empty vector control
mESC line in their ability to undergo neural differenti-
ation. We first assessed the proliferation rate of the Npas4
knockdown lines to determine whether knockdown of
Npas4 resulted in a gross change in proliferation or cell
death during neural differentiation. We compared the pro-
liferation rate of Npas4 knockdown mESC lines to that of
the Empty vector control mESC line by counting the total
number of viable cells at 24 hour intervals over ten days
of differentiation for each cell line. We found that therewas no statistically significant difference in proliferation
rate between the Npas4 knockdown lines and the Empty
vector control mESC line when analyzed using non-linear
regression, P = 0.2739 (Figure 4A).
Figure 4 The effect of reduced Npas4 expression on Sox1 expression during neural differentiation of mESCs. (A) The cell proliferation
rate during neural differentiation was measured by counting the total number of viable cells at 24 hour intervals. Means and standard deviations
of three independent experiments are shown (n = 3). There was no statistically significant difference between the Npas4 knockdown lines and
the Empty vector control mESC line (P = 0.2739, non-linear regression). (B) Temporal analysis of Sox1GFP expression during N2B27 differentiation
of Npas4 knockdown and control mESCs as measured by flow cytometry. Means and standard deviations of three independent experiments are
shown (n = 3). There was a statistically significant difference between each of the Npas4 knockdown mESC lines and the Empty vector control
mESC line (****P ≤0.0001, two-way ANOVA). There was no statistically significant difference between the Empty vector control mESC line and the
parental 46C mESC line (P = 0.1898 , two-way ANOVA). (C) Sox1GFP expression at Day 7 of neural differentiation. Representative flow cytometry
histograms are shown for each mESC line. The y-axis shows the number of cells counted while the x-axis shows the GFP fluorescence intensity.
The gate used to count GFP+ cells is shown. ANOVA, analysis of variance; mESC, mouse embryonic stem cells.
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during neural differentiation of mESCs (Figure 1A, 1B, 1D)
suggested that Npas4 may be expressed by a transient pro-
genitor cell type as the period of peak Npas4 expression
corresponded to the phase of differentiation marked by
the proliferation of NPCs [39]. Thus, to determine the
effect of Npas4 knockdown on NPCs formation, flow cy-
tometry was used to evaluate the occurrence of Sox1+
NPCs in both Npas4 knockdown and control mESCsduring neural differentiation. To ensure that background
auto-fluorescence did not interfere with detection of
Sox1GFP expression, the D3 mESC line [38], which does
not carry the gene coding for GFP in its genome, was used
as a negative control.
The Sox1GFP expression profile of the Empty vector
control mESC line was comparable to that of the 46C
parental mESC line and no statistically significant dif-
ference was detected when the two cell lines were
Figure 5 The effect of reduced Npas4 expression on Nestin
expression during neural differentiation of mESCs. (A)
Immunocytochemical analysis of Nestin expression (green) during
neural differentiation. Representative images of cultures are shown
for each mESC line at Day 6 to 9 of N2B27 differentiation. Cells were
counterstained with DAPI to visualize nuclei (blue). Scale bar = 100 μm.
(B) Quantification of Nestin expression in Npas4 knockdown and
control mESC lines at various stages of neural differentiation. For each
field, the overall fluorescence intensity was calculated for each color
channel and from this the ratio of Nestin:DAPI fluorescence was
determined. Means and standard deviations of three independent
experiments are shown (n = 3). Over the course of the differentiation
period, there was a statistically significant difference in the Nestin:DAPI
ratio between the Empty vector control line and each of the Npas4
knockdown lines (Empty versus KD1, **P <0.01; Empty versus KD2,
**P <0.01) when analyzed using a two-way ANOVA. ANOVA, analysis
of variance; DAPI, 4',6-diamidino-2-phenylindole; mESC, mouse
embryonic stem cells.
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In both cell lines, the proportion of GFP+ cells steadily
increased between Days 3 and 5 reaching a peak of
approximately 80% GFP+ cells between Days 6 and 7
before gradually declining. Analysis of Npas4 knockdown
mESC cultures revealed that the Sox1GFP expression pro-
files for these cell lines had a similar pattern to those of
the control mESC lines although the maximum percent-
age of GFP+ cells attained was considerably lower. The
highest percentage of GFP+ cells recorded in KD1 cultures
was 60%, while in KD2 cultures this figure was only 40%.
Over the course of the differentiation period, the differ-
ence in the percentage of GFP+ cells generated between
the Empty vector control mESC line and each of the
Npas4 knockdown mESC lines was statistically significant
when tested using a two-way ANOVA (P <0.0001). Repre-
sentative histogram plots of GFP fluorescence intensity re-
corded on Day 7 of differentiation are shown in Figure 4C.
These data suggest that reduced Npas4 expression during
neural differentiation of mESCs resulted in a decrease in
the proportion of cells expressing Sox1.
We next analyzed Npas4 knockdown and Empty vector
control cultures for expression of another NPC marker,
Nestin, using immunohistochemistry. The Nestin gene en-
codes an intermediate filament protein whose expression
is specific to CNS progenitor cells [45]; however, in the
embryonic CNS Nestin is expressed at a later stage of
differentiation than Sox1 [46] and thus Nestin+ cells
represent a more mature type of NPC. After four days
of differentiation, no statistically significant difference
was observed between mESC lines in the percentage of
cells expressing Nestin (Additional file 5). However,
during the later stages of differentiation a clear trend
emerged. From Day 6 to Day 9, there was a steady de-
cline in the proportion of Nestin+ cells present in Empty
vector control cultures as these NPCs differentiated into
post-mitotic neurons, which was in contrast to the Npas4
knockdown cultures where the proportion of Nestin+ cells
remained constant (KD1) or even increased (KD2) over
the same period (Figure 5). Over the course of this four
day differentiation period, there was a statistically signifi-
cant difference in the Nestin:DAPI ratio between the
Empty vector control line and each of the Npas4 knock-
down lines (Empty versus KD1, **P <0.01; Empty versus
KD2, **P <0.01) when analyzed using a two-way ANOVA.
These data indicate that Nestin remains expressed for a
longer period of time when Npas4 expression is reduced
which suggests that neural differentiation may be stalled
or delayed in Npas4 knockdown cultures.Discussion
The possible role of Npas4 during neurodevelopment
and neuronal differentiation is a topic that has receivedlittle attention to this point, despite there being evidence
that it may indeed be involved in these processes. Yun
et al. showed that Npas4 mRNA is up-regulated during
neuronal differentiation of the Neuro2a neuroblastoma
cell line and that Npas4 plays an important role in pro-
moting neurite outgrowth in both Neuro2a cells and
hippocampal neurons [47]. Here, we expand on these
observations and demonstrate for the first time that
Npas4 is also expressed during neural differentiation of
both mouse and human ESCs and that it may play a role
in the progression of neural progenitor cells along the dif-
ferentiation route. In both neural differentiation models,
Npas4 expression was transient and occurred prior to the
emergence of neurons in culture. We speculate that Npas4
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transiently prior to terminal differentiation into post-
mitotic neurons and glia. This assertion is supported by
data from the hESC model where NPAS4 was selectively
expressed in Noggin-treated hESCs but was down-
regulated once cells had progressed to the neurosphere
stage. Treatment of hESCs with Noggin converts them into
a population of committed early NPCs; after 14 days of
treatment the majority of cells in culture are PAX6+/
SOX1− cells with very few PAX6+/SOX1+ cells present
[43]. These PAX6+/SOX1− NPCs cells have a distinct
anterior identity and have been referred to as ‘primitive
anterior neurectoderm’ (PAN) [48]. Replating the Noggin-
treated cells triggers further differentiation and formation
of neurospheres, which represent a more mature type
of NPC population that also expresses PAX3. We
hypothesize that during neural differentiation Npas4 is
expressed by the PAN cell population and this is sup-
ported by the specific expression of Npas4 that is seen
in the developing forebrain of the mouse embryo.
Interestingly, it has been reported that a small number
of Npas4+ cells in the dentate gyrus of adult mice co-
express markers of dividing cells such as Sox2 and
doublecortin [49] which suggests that expression of
Npas4 in NPCs is not limited to the developmental
period.
We also demonstrate that reduced Npas4 expression
in mESCs undergoing neural induction resulted in de-
layed neural differentiation. In these cultures we found
that there were fewer Sox1+ cells and that expression of
Nestin persisted longer than in control cultures. Inter-
estingly, in both cases we observed a more pronounced
effect in the cell line having a greater reduction in Npas4
expression. This suggests that the severity of the pheno-
type is proportional to the level of Npas4 knockdown.
Given that we have achieved only partial knockdown of
Npas4 expression in this system, it is possible that an
even more significant effect would be observed by fur-
ther reducing Npas4 levels or by using mESCs obtained
from Npas4−/−mice.
Differentiation of ESCs is commonly used to model
the events occurring in the embryo during the early
stages of development [36,37]. Accordingly, our obser-
vations in vitro suggested that Npas4 may be involved
in aspects of early nervous system development in vivo.
This was substantiated by our analysis of Npas4 expres-
sion in the mouse embryo where we detected mRNA
expression in the developing forebrain at E9.5 and
E10.5. No expression was observed at the earlier stage
of E8.0 and as later embryonic stages were not investi-
gated it is not known whether Npas4 expression is
maintained until birth or is only transiently expressed
as was seen in vitro. More research is needed to address
this question.Curiously, the temporal relationship between Npas4
and Sox1 expression differed in the ESC differentiation
models as compared to the mouse embryo. While Npas4
appears to be expressed prior to or concurrently with
Sox1 in the in vitro differentiation systems, this seemed
to be reversed in vivo. During embryogenesis Sox1 expres-
sion coincides with the neural induction of ectoderm at
E7.5 [50] when it is expressed specifically in the neural
plate [51] and it continues to be expressed in the neural
tube along the entire anterior/posterior axis at later stages
of neurodevelopment [50]. This places Sox1 expression
several days ahead of Npas4 expression which we were
unable to detect prior to E9.5 (Figure 2). While this seems
to contradict the in vitro data, it should be noted that dif-
ferentiation of ESCs in vitro is not a perfect model of em-
bryonic development and that some differences may exist
between the simplified in vitro model and the complexity
of the whole embryo.
Nevertheless, these observations suggest that our loss-
of-function studies in vitro may have relevance in vivo.
The period between E7.5 to E10.5 is a critical time in
the embryo when development of the nervous system
begins and it is marked by several important events. At
E7.5, secretion of diffusible dorsalizing signals, such as
Noggin, triggers neural induction in which a region of
the ectoderm becomes specifically defined as the neu-
roectoderm [52]. By E8.5, neural specification is largely
complete and the resulting neural plate begins to fold
onto itself to form the neural tube in a process known
as neurulation which terminates at around E10 with the
final closure event [53]. The timing of Npas4 expression
and its specific localization in the rudimentary forebrain
structures raise the possibility that it may be involved in
the specification of forebrain identity. However, unravel-
ling the role of Npas4 in embryogenesis and determining
precisely which cell populations express this transcrip-
tion factor will require further investigation. A thorough
exploration of the developmental biology of Npas4-null
embryos, particularly the expression patterns of Sox1 and
Nestin, may provide valuable information towards this end.
While the findings from this study suggest that Npas4
could have a role in early developmental processes, the
study of Npas4−/−mice has thus far not revealed any
clear embryological function for Npas4. Npas4−/−mice
do not show any gross morphological abnormality at
birth and they are able to generate offspring in the
expected Mendelian ratios [7,9]. While these obser-
vations demonstrate that the Npas4 gene is not essen-
tial for embryonic survival, we would suggest that,
based on our results, further detailed investigation of
Npas4−/−mice during the early stages of embryogenesis
is warranted. There are numerous examples of genes
that have roles in important developmental processes
but do not show a profound developmental phenotype
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pensation by other genes having similar functions.
For instance, the Sox1 gene is specifically expressed
in the neural plate during early CNS development
[51] and is involved in maintenance of NPCs [46,54], yet
Sox1−/−mice are viable, born in the expected Mendelian
ratios and show no obvious signs of developmental
abnormalities [55].
Indeed, there is evidence to suggest that alternative
pathways are activated in Npas4−/−mice to compensate for
the lack of Npas4 protein. For example, Lin and colleagues
remarked that although frequencies of miniature inhibi-
tory post-synaptic currents (mIPSCs) were similar in hip-
pocampal slices prepared from Npas4+/+and Npas4−/−mice,
a clear difference was seen between Npas4 knockdown
and controls when RNAi was used to acutely reduce
Npas4 expression in wildtype slices [7]. Similarly,
Ramamoorthi et al. noted that while there was reduc-
tion in the expression of certain Npas4 target genes in
Npas4 global knockout mice, conditional deletion of
Npas4 in adult mice resulted in an even more pro-
nounced reduction in target gene expression [8]. Both
of these observations imply that the presence or
absence of Npas4 during embryonic development can
influence which developmental programs are activated.
A complete absence of Npas4 during embryonic devel-
opment appears to trigger various Npas4-independent
compensatory pathways that allow embryonic develop-
ment to proceed relatively normally such that the resulting
animal can function without the need for Npas4 activity.
On the other hand, it seems that in wildtype animals,
where Npas4 is an integral part of development, the neural
pathways that are produced are reliant on Npas4 function
and the sudden removal of Npas4 from the system has
devastating effects. Presumably, this type of gene compen-
sation is more likely to occur in the intact organism where
there are many feedback mechanisms in place to ensure
that development can proceed normally. In contrast to the
complex environment that is an embryo, a simplified two-
dimensional cellular model of development that lacks
these sophisticated feedback mechanisms is likely to be
much more susceptible to perturbations in gene expres-
sion. This may explain why sometimes certain phenotypes
can be elicited by gene knockdown in vitro, yet they are
not detectable in the knockout embryo.
In mESCs cultures having reduced levels of Npas4 we
observed that expression of Sox1 was affected which
raises the possibility that Npas4 acts upstream of Sox1
and may participate in the regulation of Sox1 expression.
If Npas4 does indeed influence expression of Sox1, then
it would be expected that in the Npas4−/−mouse there
would be some evidence of disrupted Sox1 function.
Interestingly, there is some similarity between the
Npas4−/−and Sox1−/−mice; both knockout mice displaya hyperexcitability phenotype. One of the features of the
Sox1−/−phenotype is enhanced synaptic activity in the ol-
factory cortex which manifests as spontaneous epilepti-
form discharges and ultimately results in spontaneous
limbic seizures beginning at four to six weeks of age
[55,56]. Given that Npas4−/−mice display a similar hyper-
excitability phenotype and are also prone to seizures [7], it
is tempting to speculate that there may be a common
underlying mechanism. In summary, our work highlights
a potential role for Npas4 in neural differentiation during
CNS development.
Conclusions
Our findings provide the first evidence that Npas4 is
expressed by a progenitor cell type in the context of
mammalian development and that Npas4 expression is
required for the normal progression of neural progenitor
cells along the differentiation route. While these findings
suggest that Npas4 may be involved in aspects of NPC
biology, such as NPC maintenance and/or differentiation,
further research is needed to confirm the developmental
role of Npas4 in vivo.
Additional files
Additional file 1: Primer sequences and PCR conditions used for
each primer set. aThese primers were designed for mouse transcripts
and therefore contained some nucleotide mismatches to human cDNA
sequences (underlined); however, they successfully generated RT-PCR
products of the expected size (Npas4 primers - 348 bp; β actin primers -
511 bp) when used in reactions containing cDNA derived from
human samples.
Additional file 2: Verification of anti-Npas4 antibody specificity. The
anti-Npas4 antibody was able to detect a protein of approximately
100 kDa in HEK 293 T cells transfected with a recombinant Npas4
expression construct (rNpas4) while no signal was observed in
untransfected HEK 293 T cells (n = 3). The expression vector contained
the cDNA sequence coding for the mouse Npas4 protein in which the
stop codon had been removed and replaced with two copies of the
sequence coding for a Myc epitope placed in tandem. The Myc
sequences were positioned in frame and were followed by a stop codon
such that translation of the resulting mRNA would yield the mouse
Npas4 protein fused to two C-terminal Myc tags. An antibody to the
reference protein β-actin was used as a loading control.
Additional file 3: Temporal expression of GFP during N2B27
differentiation of the 46C transgenic mESC line. GFP expression is
under the control of the endogenous Sox1 promoter as visualized by
fluorescence microscopy (n ≥3). Scale bars = 100 μm.
Additional file 4: Assessment of the pluripotency status of
transduced mESC lines. (A) Stable integration of shRNA constructs into
the mESC genome was confirmed by genomic PCR using primers
specific to the integration fragment. After 10 passages or more, genomic
DNA was isolated from mESC lines that were virally transduced with
shRNA expression constructs and also from the untransduced 46C
parental mESC line. Primers to the β-actin gene were used as a positive
control for genomic DNA isolation. The negative control reaction (−)
contained water in place of template genomic DNA. (B) mESC lines were
assessed for expression of the pluripotency genes Pou5f1 and Nanog
using RT-PCR (n = 3). (C) Percentage of colonies expressing alkaline
phosphatase in undifferentiated mESC lines as determined by an alkaline
phosphatase detection assay. Means and standard deviations of three
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difference was observed between mESC lines. P = 0.5078 (one-way
ANOVA). (D) Representative images of colonies from each mESC line after
alkaline phosphatase detection assay (Fast Red Violet staining). Scale
bar = 100 μm. (E) Comparison of the morphology of undifferentiated
mESC lines. Scale bar = 100 μm. (F) Comparison of growth rate between
mESC lines. Means and standard deviations of four independent
experiments are shown (n = 4). No statistically significant difference was
observed between slopes using linear regression. P = 0.115.
Additional file 5: Analysis of Nestin expression in various mESC
lines after four days of neural differentiation in N2B27 medium.
(A) Immunocytochemical analysis of Nestin expression (red) during neural
differentiation. Representative images of cultures after four days of
differentiation are shown for each mESC line. Cells were counterstained
with DAPI to visualize nuclei (blue). Scale bar = 100 μm. (B) Quantification
of Nestin expression in Npas4 knockdown and control mESC lines after
four days of differentiation. The number of Nestin-expressing cells
(Nestin+, DAPI+) was counted manually by a blinded researcher and
expressed as a percentage of total cells (DAPI+). Means and standard
deviations of four independent experiments are shown (n = 4). No
statistically significant difference was observed between the Empty vector
control and the Npas4 KD1 mESC line (P = 0.4203, unpaired t test) or the
Npas4 KD2 mESC line (P = 0.1614, unpaired t test).
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